Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Xbrane Biopharma AB
Pharmaceutical Preparation ManufacturingSwedenSTO: XBRANE.ST
Last verified 1 year agoxbrane.com
Xbrane Biopharma AB, a pioneering biotechnology company headquartered in Sweden, focuses on the development of innovative biosimilars and biologics. Founded in 2006, Xbrane has made significant strides in the biopharmaceutical industry, particularly in the fields of ophthalmology and oncology.
The company is renowned for its flagship product, Xlucane, a biosimilar to Lucentis, which addresses serious eye diseases and showcases Xbrane's commitment to enhancing patient care through affordable treatment options. With a strong presence in Europe and expanding operations globally, Xbrane Biopharma has established itself as a key player in the biosimilar market, recognised for its rigorous development processes and high-quality standards.
As Xbrane continues to advance its pipeline, it remains dedicated to delivering innovative solutions that meet the evolving needs of healthcare providers and patients alike.
29
DitchCarbon score
-13 vs industry average
Xbrane Biopharma AB’s score of 29 is higher than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Xbrane Biopharma AB?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Emissions trajectory 2020 – 2028
202020212022202320242025202620272028
Reported emissions
Scope 1
•••kg CO₂e
Scope 2
•••kg CO₂e
Scope 3
•••kg CO₂e
Total reported
•••kg CO₂e
Scope 3 accounts for ••• of total emissions.
Xbrane Biopharma AB's reported carbon emissions
In 2025, Xbrane Biopharma AB reported total emissions of approximately 3,000 kg CO2e, with Scope 2 emissions accounting for about 2,000 kg CO2e. The company has set ambitious climate commitments, aiming to reduce its Scope 2 emissions to near zero by 2025 and achieve a 50% reduction from a 2020 baseline by 2030. Additionally, Xbrane is targeting a near-zero reduction for its Scope 1 emissions by 2025.
In 2023, the company reported Scope 2 emissions of approximately 8,000 kg CO2e, contributing to a combined Scope 1 and 2 total of about 9,000 kg CO2e. In 2022, Scope 2 emissions were approximately 10,000 kg CO2e, with no reported Scope 1 emissions during that year.
Xbrane Biopharma AB's climate initiatives reflect a strong commitment to sustainability and reducing its carbon footprint, aligning with industry standards for climate action.
Assessing Xbrane Biopharma AB as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Xbrane Biopharma AB and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Xbrane Biopharma AB’s Climate Goals (2030 & 2050)
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
On track94%
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
At risk48%
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Behind target22%
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
See details
Not active
Carbon Disclosure Project
See details
Not active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Xbrane Biopharma AB1 year ago
29
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more